ResearcherTianjin Medical University General HospitalNo recent work listed

Tiantian Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2845-5413; OpenAlex author ID A5073445421. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

MiR-506 Promotes Antitumor Immune Response in Pancreatic Cancer by Reprogramming Tumor-Associated Macrophages toward an M1 Phenotype. Co-author DOI 10.3390/biomedicines11112874 ↗
IGFBP2 Drives Regulatory T Cell Differentiation through STAT3/IDO Signaling Pathway in Pancreatic Cancer. Co-author DOI 10.3390/jpm12122005 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Longhao Sun · 2 shared papers, 2022–2023 · strength 0.42
- Paper MiR-506 Promotes Antitumor Immune Response in Pancreatic Cancer by Reprogramming Tumor-Associated Macrophages toward an… DOI 10.3390/biomedicines11112874 ↗
- Paper IGFBP2 Drives Regulatory T Cell Differentiation through STAT3/IDO Signaling Pathway in Pancreatic Cancer. DOI 10.3390/jpm12122005 ↗
Xiaoyu Liang · 1 shared paper, 2022 · strength 0.19
- Paper IGFBP2 Drives Regulatory T Cell Differentiation through STAT3/IDO Signaling Pathway in Pancreatic Cancer. DOI 10.3390/jpm12122005 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.